Analyst Research Report Snapshot

Title:

Valeant Pharmaceuticals International, Inc.

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

13 Jan 2015

Pages:

44

Type:

AcrobatPDF

Companies referenced:

Available for Immediate Download
Summary:

Valeant Pharmaceuticals International (Valeant) operates as a multinational specialty pharmaceutical company. It develops, manufactures and markets pharmaceutical products and medical devices. The company operates in Americas, Europe, Asia, Middle East and Africa. It is headquartered in Quebec, Canada and employs around 7,000 people. The company recorded revenues of $3,546.6 million in the fiscal year ended December 2012, an increase of 44% over 2011. The company's operating profit was $79.7 million in fiscal 2012, a decrease of 73.4% compared to 2011. Its net loss was $116 million in fiscal 2012, as compared to the net profit of $159.6 million in 2011.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.